Vicore Pharma Holding AB's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Vicore Pharma Holding AB is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
Gross Profit	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
EBIT	kr -62.81M	kr -68.57M	kr -64.34M	kr -90.96M	kr -83.52M
EBITDA	kr -62.81M	kr -68.57M	kr -64.34M	kr -90.96M	kr -83.52M
Net Income Common Stockholders	kr -60.70M	kr -68.48M	kr -65.87M	kr -93.37M	kr -80.38M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 261.74M	kr 169.75M	kr 236.56M	kr 300.62M	kr 371.20M
Total Assets	kr 338.01M	kr 250.18M	kr 321.49M	kr 377.74M	kr 451.17M
Total Debt	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
Net Debt	kr -261.74M	kr -169.75M	kr -236.56M	kr -300.62M	kr -371.20M
Total Liabilities	kr 48.92M	kr 89.48M	kr 93.41M	kr 86.52M	kr 67.85M
Stockholders Equity	kr 289.08M	kr 160.70M	kr 228.08M	kr 291.22M	kr 383.32M
Cash Flow	-
Free Cash Flow	kr -100.27M	kr -66.74M	kr -64.27M	kr -71.65M	kr -75.27M
Operating Cash Flow	kr -100.27M	kr -66.74M	kr -61.27M	kr -71.65M	kr -75.27M
Investing Cash Flow	kr 0.00	kr 0.00	kr -3.00M	kr 77.00M	kr 0.00
Financing Cash Flow	kr 187.27M	kr -106.00K	kr -63.00K	kr -63.00K	kr -63.00K

Currency in SEK

Vicore Pharma Holding AB Earnings and Revenue History

Income Statement >

Vicore Pharma Holding AB Debt to Assets

Balance Sheet >

Vicore Pharma Holding AB Cash Flow

Cash Flow >

Vicore Pharma Holding AB Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing